[Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
Zhang
Ying-Jun
YJ
Department of Pharmacology, Hebei Medical University, Shijiazhuang 050017, China.
Dong
Lan-Feng
LF
Wang
Yong-Li
YL
D000818:Animals; D019703:Calcineurin / Q000235:genetics / Q000502:physiology*; D006332:Cardiomegaly / Q000235:genetics / Q000503:physiopathology* / Q000517:prevention & control; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use; D015870:Gene Expression; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D050778:NFATC Transcription Factors / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D016559:Tacrolimus / Q000494:pharmacology / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D050778:NFATC Transcription Factors; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus